We utilize cutting-edge technologies and techniques such as Coolsculpting, Medical Weight Loss with Semaglutide, and the amazing Emsculpt Neo to deliver optimal results and help you achieve your ideal weight and body
Internal Reference Links External Reference Databases For general registry background and independent research context, external scientific databases may be consulted
PubMed laboratory research record [PMID: 7618452] PubMed record related to this compound for laboratory literature review
M.LillvisJ
Phase 2 trial (NEJM, 2023) The landmark Phase 2 trial, published in the New England Journal of Medicine, randomized 338 adults with obesity to receive weekly subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks